Category: colorectal cancer

Stool-based Colorectal Cancer Screening in the COVID-19 Era

a figure with the colon highlighted and a COVID-19 virus

The COVID-19 pandemic continues to exact a devastating public health toll and in many indirect ways. While people work from home and avoid social contact, many may also be skipping important preventive care. Findings released in May of 2020 indicated a drop of between 86% and 94% in preventive cancer screenings in 2020 compared with Read More >

Posted on by W. David Dotson, Muin J. Khoury, M. Scott Bowen Office of Genomics and Precision Public Health, Office of Science; & Nicole F. Dowling, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health PromotionLeave a commentTags

Should polygenic risk scores be used in risk-stratified colorectal cancer screening?

a polygenic risk score bell and a body with a colon being exposed

Polygenic risk scores (PRS) summarize information about a person’s disease risk based on numerous DNA variants in their genome. Each variant confers very little increase in disease risk. But composite (or polygenic) risk scores made up of a number of such variants have been shown to stratify people to normal distributions of disease risks for Read More >

Posted on by W. David Dotson, Office of Genomics and Precision Public Health, Office of Science; Nicole F. Dowling, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; & Muin J. Khoury, Office of Genomics and Precision Public Health, Office of Science, Centers for Disease Control and Prevention, Atlanta, GeorgiaLeave a commentTags

Can an Aspirin a Day Prevent Colorectal Cancer in People with Lynch Syndrome?

a hand holding a pill with several other pills on the table and a pill bottle and a body with an exposed colon

Encouraging news for group at much greater risk of CRC Lynch syndrome (LS) is the most common cause of hereditary colorectal (colon) cancer (CRC). People with LS have a 50-70% risk of developing CRC in their lifetimes – far higher than the 4% risk within the general population where CRC is a leading cause of Read More >

Posted on by Scott Bowen, Office of Public Health Genomics; Nicole Dowling, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GeorgiaLeave a commentTags

When Should You Be Screened for Colorectal Cancer?

DNA and a person with their colon shown

Starting at the right time saves lives. People with a family history of CRC may need to start much earlier. Doctors and public health professionals strive to live by the creed “First, do no harm” but often wrestle with difficult choices, including when and how often screening tests should be conducted. Effective prevention of colorectal Read More >

Posted on by Scott Bowen, Office of Public Health Genomics; Lisa Richardson, Division of Cancer Prevention and Control; and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GeorgiaLeave a comment

Making Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network

flow chart individual

Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers.  Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities.   Read More >

Posted on by Deb Duquette, MS, CGC & Sarah Mange, MPH- Michigan Department of Community Health; Cecelia Bellcross, PhD, MS- Emory University; Heather Hampel, MS, CGC- The Ohio State University; Kory Jasperson, MS, CGC- Huntsman Cancer Institute (Authors are all from the Lynch Syndrome Screening Network (LSSN) Founding Board of Directors)1 CommentTags , , , , ,